Building Novel DNA Constructs at ASM
News May 14, 2013
Integrated DNA Technologies (IDT) will host a user-orientated product theater presentation at the American Society of Microbiology (ASM) annual meeting (18-21 May, Denver, Colorado).
The presentation entitled ‘Rapid and Reliable Gene Construction with gBlocks™ Gene Fragments and Gibson Assembly™ Method’ will take place on 20 May, 11:00 am - 11:45 am in the Exhibit Hall, booth #1307.
Led by Dr Michel Cannieux, Director of Product Management at IDT, the presentation will offer first hand advice for bench scientists looking to build and modify novel DNA constructs with ease and speed.
Overcoming the costs and inefficiencies associated with traditional PCR techniques for the assembly of novel genes, IDT gBlocks Gene Fragments can be designed up to 500 base pairs and multiple fragments can be easily assembled for the generation of larger gene constructs.
The presentation will guide attendees through this process, offering practical advice for protocols and best practices, while providing insight into the wide range of biological applications and troubleshooting recommendations.
The workshop will give scientists a take-away understanding of how gBlocks can be used to proficiently build novel DNA sequences using the Gibson Assembly Method, in a more cost-effective, dependable manner.
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE
Scientists report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.